How Yonalimab Differs from Rituximab

Hanny contrasts yonalimab's B‑cell maturation effects and BAFF‑R blockade with rituximab's lack of disease modification and BAFF increase.

Play episode from 05:39

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!